Surmodics, Inc. announced new real-world results from the PROWL registry evaluating the company’s Pounce thrombectomy pl ...

Critical Limb Ischemia companies are Boston Scientific Corporation, AnGes, Inc., Mitsubishi Tanabe Pharma, B. Braun Melsungen AG, Medtronic Endovascular, Ixaka Ltd ...

For patients with chronic, limb-threatening ischemia due to atherosclerosis that affects the arteries below the knee, a revascularization strategy using endovascular treatment as the first option was ...

The objective of this study was to review a single center's experience of upper limb revascularization over 20 years. All patients undergoing operative or endovascular upper limb revascularization ...

Peripheral artery disease, or PAD, is a condition where the arteries become narrow or blocked over time, most often affecting ...

In patients with critical limb ischemia (CLI), endovascular therapy results in a high rate of limb salvage and improvement in quality of life (QOL), according to results from a prospective Japanese ...

According to Coherent Market Insights (CMI), the global critical limb ischemia market size is projected to expand at a CAGR of 8.8%, growing from USD 5.55 Bn in 2025 to USD 10.02 Bn by 2032. Based on ...

Following angioplasty, patients with critical limb ischemia (CLI) due to pure isolated infrapopliteal disease assigned antiplatelet therapy with a combination of aspirin and cilostazol experienced ...

For patients presenting with critical limb ischemia at a single center in Australia, the shift to an endovascular-first revascularization strategy reduced the rate of major amputations and the length ...

A study documents poor outcomes among hospitalized patients with kidney failure and critical limb ischemia who did not receive dialysis. Critical limb ischemia is common among patients with end-stage ...

Insights from PERT/DVT, limb salvage, and aortic team members on effective networking that lasts longer than the launch ...